|
|
1.
|
Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: Pooled 12-month outcomes of BIOSOLVE-II and BIOSOLVE-III. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2018
Citation: - Catheterization & Cardiovascular Interventions. 92(7):E502-E511, 2018 Dec 01.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Abizaid A, Alves Lemos P, Barbato E, BIOSOLVE-II and III investigators, Christiansen EH, Garcia-Garcia HM, Haude M, Ince H, Kische S, Tolg R, Van Mieghem NM, Verheye S, von Birgelen C, Waksman R
|
|
|
2.
|
Scaffold thrombosis following implantation of the ABSORB BVS in routine clinical practice: Insight into possible mechanisms from optical coherence tomography. MedStar authors:
- Garcia-Garcia, Hector M
- Kajita, Alexandre H
Year: 2018
Citation: - Catheterization & Cardiovascular Interventions. 92(2):E106-E114, 2018 08 01.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Arkenbout EK, de Winter RJ, Garcia-Garcia HM, Henriques JPS, Kajita AH, Kraak RP, Piek JJ, Tijssen JGP, van der Schaaf RJ, Wykrzykowska JJ
|
